References
- Andreas Z, Jorg K. (1995). Microspheres and nano particles used in ocular delivery systems. Adv Drug Del Rev 16:61–70
- Balasubramanium J, Kant S, Pandit J. (2003). In vitro and in vivo evaluation of the Gelrite® gellan gum-based ocular delivery system for indomethacin. Acta Pharma 53:251–61. https://doi.org/http://www.ncbi.nlm.nih.gov/pubmed/14769232
- Dengning X. (2010). Preparation of stable nitrendipine nanosuspensions using the precipitation–ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm 40:325–34
- Guana J. (2011). Optimized preparation of levofloxacin-loaded chitosan nanoparticles by ionotropic gelation. Phy Proc 22:163–9
- Hany MA, Peter Y, Nicholas B. (2009). Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int J Pharm 375:107–13
- Hongyi Q. (2007). Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm 337:178–87
- Ibrahim MM, Abd-Elgawad AE, Soliman OA, Jablonski MM. (2013a). Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release. J Pharm Sci 102:1036–53
- Ibrahim MM, Abd-Elgawad AE, Soliman OA, Jablonski MM. (2013b). Novel topical ophthalmic formulations for management of glaucoma. Pharm Res 30:2818–31
- Johan C, Katarina E, Roger P, Katarina J. (1998). Rheological evaluation of Gelrite in situ gels for ophthalmic use. Eur J Pharm Sci 6:113–19
- Kassem MA. (2007). Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm 340:126–33
- Katiyar S, Pandit J, Mondal RS, et al. (2014). In situ gelling dorzolamide loaded chitosan nanoparticles for the treatment of glaucoma. Carbohydr Polym 102:117–24
- Koichi B. (2011). A method for enhancing the ocular penetration of eye drops using nanoparticles of hyrolyzable dye. J Control Release 153:278–87
- Kortejarvi H, Yliperttula M, Dressman JB, et al. (2005). Bio waiver monographs for immediate release solid oral dosage forms: ranitidine hydrochloride. J Pharm Sci 94:1617–25
- Lou J, Hu W, Tian R, et al. (2014). Optimization and evaluation of a thermo responsive ophthalmic in situ gel containing curcumin loaded albumin nanoparticles. Int J Nanomed 9:2517–25
- Mehrdad H, Amir A, Pedram R. (2008). Hydrogel nanoparticles in drug delivery. Adv Drug Del Rev 60:1638–50
- Nagarwal R, Kumar R, Dhanwant M, Pandit JK. (2011). Modified PLA nano in situ gel: a potential ophthalmic drug delivery system. Colloids Surf B Biointerfaces 86:28–35
- Niederer RL, McGhee NJ. (2010). Clinical in vivo confocal microscopy of the human cornea in health and disease. Prog Retinal Eye Res 29:30–58
- O’Brien TP. (2012). Besifloxacin ophthalmic suspension, 0.6%: a novel topical fluoroquinolone for bacterial conjunctivitis. Adv Ther 29:473–90
- Paulsson M, Hagerstrom H, Edsman K. (1999). Rheological studies of the gelation of deacetylated gellan gum (Gelrite) in physiological conditions. Eur J Pharm Sci 9:99–105
- Rathapon A, Suthira T, Asira F, Sukitaya V. (2011). Optimization and evaluation of thermo responsive diclofenac sodium ophthalmic in situ gels. Int J Pharm 411:128–35
- Rosario P. (2002). Eudragit RS100 nano-suspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci 16:53–61
- Singh J, Chhabra G, Pathak K. (2014). Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study. Drug Dev Ind Pharm 40:1223–32
- Taís G. (2010). A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm 75:186–93
- Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. (2013). Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm 443:293–305
- Wavikar PR, Vavia PR. (2014). Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery. J Liposome Res 9:1–9
- Xiangrong S. (2008). Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm 69:445–3